Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“likely reflects selection over the chloroquine-resistant mdr1 N86 mutant following the nationwide shift from chloroquine to artemether–lumefantrine [44,53].”
From High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia (2025) · cites this paper as [44]
In the citing paper
“This variant, which reduces lumefantrine susceptibility”
From High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia (2025) · cites this paper as [44]
In the citing paper
“we confirmed previous reports of wild-type mdr1 N86 near fixation [44,51,52].”
From High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia (2025) · cites this paper as [44]
In the citing paper
“Similarly, the high prevalence of PfCRT CVIET (61.2%) reflects ongoing chloroquine pressure from P. vivax treatment in co-endemic areas52, while wild-type CVMNK persists in low P. vivax settings, reaching 95.1% in Guba.”
From Genomic surveillance reveals co-occurrence of Plasmodium falciparum drug resistance variants across diverse transmission settings in Ethiopia (2026) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carrara, V. I., Lwin, K. M., Phyo, A. P., Ashley, E., Wiladphaingern, J., Sriprawat, K., Rijken, M., Boel, M., McGready, R., Proux, S., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001398 · Cited by 185
Research works printed but not linked: 44
- Achieng, 2015, Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya, Int J Parasitol Drugs Drug Resist, 5, 92, 10.1016/j.ijpddr.2015.05.005 · DOI
- Baidjoe, 2013, Combined DNA extraction and antibody elution from filter papers for the assessment of malaria transmission intensity in epidemiological studies, Malar. J., 12, 272, 10.1186/1475-2875-12-272 · DOI
- Baliraine, 2011, Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda, JID (J. Infect. Dis.), 204, 1120, 10.1093/infdis/jir486 · DOI
- Baraka, 2018, Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda, PLoS One, 13, 10.1371/journal.pone.0191922 · doi:10.1371/journal.pone.0191922
- Barnes, 2009, Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia, Malar. J., 8, 10.1186/1475-2875-8-S1-S8 · DOI · Paper page
- Conrad, 2014, Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children, J. Infect. Dis., 210, 344, 10.1093/infdis/jiu141 · DOI
- Dagnogo, 2018, Towards a re-emergence of chloroquine sensitivity in Côte d'Ivoire?, Malar. J., 17, 413, 10.1186/s12936-018-2551-7 · DOI
- Djimde, 2001, A molecular marker for chloroquine-resistant falciparum malaria, N. Engl. J. Med., 344, 257, 10.1056/NEJM200101253440403 · DOI · Paper page
- Dokomajilar, 2006, Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic, Antimicrob. Agents Chemother., 50, 1893, 10.1128/AAC.50.5.1893-1895.2006 · DOI
- Dondorp, 2009, Artemisinin resistance in Plasmodium falciparum malaria, N. Engl. J. Med., 361, 455, 10.1056/NEJMoa0808859 · DOI · Paper page
- Duah, 2013, Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy, Malar. J., 12, 10.1186/1475-2875-12-377 · doi:10.1186/1475-2875-12-377
- Eshetu, 2010, Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia, Malar. J., 9, 226, 10.1186/1475-2875-9-226 · DOI
- Gbotosho, 2012, Different patterns of pfcrt and pfmdr1 polymorphisms in P. falciparum isolates from Nigeria and Brazil: the potential role of antimalarial drug selection pressure, Am. J. Trop. Med. Hyg., 86, 211, 10.4269/ajtmh.2012.11-0368 · doi:10.4269/ajtmh.2012.11-0368
- Geleta, 2016, Severe malaria associated with plasmodium falciparum and P. Vivax among children in Pawe hospital, Northwest Ethiopia, Malar Res Treat, 2016
- Golassa, 2014, High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia, Malar. J., 13, 120, 10.1186/1475-2875-13-120 · doi:10.1186/1475-2875-13-120
- Heuchert, 2015, Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013, Malar. J., 14, 208, 10.1186/s12936-015-0723-2 · doi:10.1186/s12936-015-0723-2
- Jima, 2005, Efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Ethiopia, East Afr. Med. J., 82, 391
- Kavishe, 2014, Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania, Malar. J., 13, 264, 10.1186/1475-2875-13-264 · doi:10.1186/1475-2875-13-264
- Keffale, 2019, Serological evidence for a decline in malaria transmission following major scale-up of control efforts in a setting selected for Plasmodium vivax and Plasmodium falciparum malaria elimination in Babile district, Oromia, Ethiopia, Trans. R. Soc. Trop. Med. Hyg., 305, 10.1093/trstmh/trz005 · DOI
- Kublin, 2003, Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi, J. Infect. Dis., 187, 1870, 10.1086/375419 · DOI · Paper page
- Leang, 2013, Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010, Antimicrob. Agents Chemother., 57, 818, 10.1128/AAC.00686-12 · DOI · Paper page
- Ljolje, 2018, Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015, Malar. J., 17, 10.1186/s12936-018-2233-5 · DOI
- Lo, 2017, Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes, PLoS Neglected Trop. Dis., 11, 10.1371/journal.pntd.0005806 · DOI
- Mekonnen, 2014, Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia, Malar. J., 13, 244, 10.1186/1475-2875-13-244 · DOI · Paper page
- Mekonnen, 2014, Re-evaluation of microscopy confirmed Plasmodium falciparum and Plasmodium vivax malaria by nested PCR detection in southern Ethiopia, Malar. J., 13, 48, 10.1186/1475-2875-13-48 · DOI
- Mohammed, 2013, Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania, Malar. J., 12, 415, 10.1186/1475-2875-12-415 · DOI
- Mula, 2011, Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia, Malar. J., 10, 214, 10.1186/1475-2875-10-214 · DOI
- Mwanza, 2016, The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia, Malar. J., 15, 10.1186/s12936-016-1637-3 · DOI
- Nyunt, 2017, Molecular evidence of drug resistance in asymptomatic malaria infections, Myanmar, 2015, Emerg. Infect. Dis., 23, 517, 10.3201/eid2303.161363 · DOI
- Okell, 2018, Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa, BMJ Glob Health, 3, 10.1136/bmjgh-2018-000999 · DOI · Paper page
- Price, 2004, Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, Lancet, 364, 10.1016/S0140-6736(04)16767-6 · DOI · Paper page
- Schunk, 2006, High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia, Malar. J., 5, 10.1186/1475-2875-5-54 · DOI
- Sisowath, 2009, In vivo selection of plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa, J. Infect. Dis., 199, 750, 10.1086/596738 · DOI · Paper page
- Sisowath, 2005, In vivo selection of Plasmodium falciparum pfmdr1 86 N coding alleles by artemether-lumefantrine (Coartem), J. Infect. Dis., 191, 1014, 10.1086/427997 · DOI · Paper page
- Snounou, 1993, Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections, Mol. Biochem. Parasitol., 58, 283, 10.1016/0166-6851(93)90050-8 · DOI · Paper page
- Sondo, 2016, Artesunate-amodiaquine and artemether-lumefantrine therapies and selection of pfcrt and Pfmdr1 alleles in Nanoro, Burkina Faso, PLoS One, 11, 10.1371/journal.pone.0151565 · DOI
- Tadesse, 2018, The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia, Clin. Infect. Dis., 66, 1883, 10.1093/cid/cix1123 · DOI · Paper page
- Taffese, 2018, Malaria epidemiology and interventions in Ethiopia from 2001 to 2016, Infect. Dis. Poverty, 7, 103, 10.1186/s40249-018-0487-3 · DOI · Paper page
- Tajebe, 2014, Detection of mixed infection level of Plasmodium falciparum and Plasmodium vivax by SYBR Green I-based real-time PCR in North Gondar, North-West Ethiopia, Malar. J., 13, 10.1186/1475-2875-13-411 · DOI
- Tsegaye, 2014, Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia, Malar. J., 13, 438, 10.1186/1475-2875-13-438 · DOI · Paper page
- Veiga, 2006, Multiplex PCR–RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum, Mol. Cell. Probes, 20, 100, 10.1016/j.mcp.2005.10.003 · DOI
- Venkatesan, 2014, Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine, Am. J. Trop. Med. Hyg., 91, 833, 10.4269/ajtmh.14-0031 · DOI · Paper page
- White, 2004, Antimalarial drug resistance, J. Clin. Investig., 113, 1084, 10.1172/JCI21682 · doi:10.1172/jci21682 · Paper page
- Xu, 2018, Surveillance of antimalarial resistance pfcrt, Pfmdr1, and Pfkelch13 polymorphisms in African plasmodium falciparum imported to Shandong Province, China, Sci. Rep., 8, 12951, 10.1038/s41598-018-31207-w · DOI
Cited by
Zeleke, A. J., Fola, A. A., Tollefson, G. A., Niaré, K., Leonetti, A., Taropawala, O., Marglous, J., Crudale, R., Brhane, B. G., Assefa, A., et al. (2025) · PLOS Pathogens · doi:10.1371/journal.ppat.1013771 · Cited by 12
Letebo, A., Vanheer, L. N., Engdaw, M., Ejigu, L. A., Hailu Alemayehu, D., Deressa, J. D., Adnew, B., Ayele, A., Bezabih, M. K., Demisse, M., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02420-5 · Cited by 4
Self-citation
Metadata
- Authors
- Hailemeskel, E., Menberu, T., Shumie, G., Behaksra, S., Chali, W., Keffale, M., Belachew, M., Shitaye, G., Mohammed, H., Abebe, D., Ashine, T., Drakeley, C., Mamo, H., Petros, B., Bousema, T., Tadesse, F. G., & Gadisa, E.
- Venue
- International Journal for Parasitology: Drugs and Drug Resistance
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 11
- Pages
- 8-12
- ISSN
- 2211-3207
- Cited by
- 21
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Netherlands Organization for International Cooperation in Higher Education (NFP-PhD.14/150)
- Center for Outcomes Research and Evaluation, Yale School of Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia. https://app.cochat.ai/papers/10.1016/j.ijpddr.2019.09.002
- The paper
- Hailemeskel, E., Menberu, T., Shumie, G., Behaksra, S., Chali, W., Keffale, M., Belachew, M., Shitaye, G., Mohammed, H., Abebe, D., Ashine, T., Drakeley, C., Mamo, H., Petros, B., Bousema, T., Tadesse, F. G., & Gadisa, E. (2019). Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia. International Journal for Parasitology: Drugs and Drug Resistance. https://doi.org/10.1016/j.ijpddr.2019.09.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.